In a prospective randomised multicentre study, the effects of cefazolin sodium and ceftizoxime on the prevention of postoperative infection were investigated in 117 patients undergoing abdominal surgery. Each drug was administered intravenously twice daily (cefazolin 4 gjday or ceftizoxime 2 gjday) for 5 days postoperatively. No statistically significant difference was noted in the incidence of infection between the 2 treated groups (cefazolin 11.5% and ceftizoxime 8.9%), and there were no serious adverse events in either group. The fever index was significantly higher in patients with postoperative infections when compared with noninfected individuals in both treatment groups, but showed no correlation with age, time of surgery or blood loss. In terms of cost, prophylactic treatment with cefazolin is recommended for such patients with a low level of anaerobic contamination.
Summary
In a prospective randomised multicentre study, the effects of cefazolin sodium and ceftizoxime on the prevention of postoperative infection were investigated in 117 patients undergoing abdominal surgery. Each drug was administered intravenously twice daily (cefazolin 4 gjday or ceftizoxime 2 gjday) for 5 days postoperatively. No statistically significant difference was noted in the incidence of infection between the 2 treated groups (cefazolin 11.5% and ceftizoxime 8.9%), and there were no serious adverse events in either group. The fever index was significantly higher in patients with postoperative infections when compared with noninfected individuals in both treatment groups, but showed no correlation with age, time of surgery or blood loss. In terms of cost, prophylactic treatment with cefazolin is recommended for such patients with a low level of anaerobic contamination.
Methicillin-resistant Staphylococcus aureus (MRSA) infection is increasing rapidly globally (Regamy et at. 1975) . In some hospitals in Japan, half the number of S. aureus infections are attributable to MRSA, which is resistant to conventional antibiotics. Third-generation cephalosporins are used widely in the treatment and prevention of infections, including those arising following upper abdominal surgery. However, although this group of antimicrobial agents is noted to have a wide spectrum of activity, it has yet to be demonstrated that this characteristic provides a clinical advantage for patients undergoing abdominal surgery.
The objective of the present prospective randomised study of patients undergoing abdominal surgery, was to compare the efficacy of a first-gen- 
Patients and Methods

Patients
A total of 117 Japanese patients admitted consecutively to hospital between October 1988 and June 1989 for surgery to treat upper digestive tract diseases such as gastric cancer, peptic ulcer, cholecystolithiasis, choledocholithiasis, gall bladder polyps, etc. were recruited to this study. Among almost all of the 12 surgical groups participating, 1 principal surgeon attended individual patients in each group. All groups submitted data relating to patients using specially designed forms, and were required to confirm collection of postoperative data relating to complications. Prior to surgery, patients were allocated to treatment using a blocked randomisation technique (cell size of 10) with the aid of computer-generated random numbers.
Boxes containing sequentially numbered, opaque, sealed envelopes were placed within the operating suite and the surgical ward. These envelopes contained the drug regimen to be used and perioperative data sheet.
Only patients requiring upper abdominal surgery were recruited to this study. Exclusion criteria included: high grade preoperative fever or infection, a history of hypersensitivity to cephalosporin or penicillin drugs, or a positive reaction to subcutaneous administration of cefazolin or ceftizoxime. Any drugs which may have affected the outcome of this study (antipyretics, ),-globulins and other antibiotics) were withheld from patients. Informed consent was obtained from all patients before participation in the study.
Methods
Following recruitment, patients were allocated to treatment with either cefazolin 2g or ceftizoxime 19 administered intravenously every 12 hours. Although the attending surgical staff determined the duration of postoperative antimicrobial therapy, it was generally recommended that such therapy be continued for at least 5 days until the patient was afebrile and showed a normal white blood cell count.
Wound infection was defined as a purulent or serous wound discharge with a positive bacteriological culture of pathogens. In contrast, serous wound discharge associated with a negative bacteriological culture and suture-related abscesses was classified as a minor wound infection. Postoperative intraperitoneal sepsis was defined as the presence of pus or fluid containing pathogenic organisms within the peritoneal cavity and detected at subsequent resection, by spontaneous discharge, by needle aspiration with the use of an organ-imaging technique, or at autopsy. Pulmonary complications were defined as the presence of positive clinical signs combined with either positive results of sputum microbiological examination, an otherwise Drug Invest. 5 (I) 1993 unexplainable body temperature> 38°C, or an abnormal chest x-ray. Urinary tract infection was defined as the presence of more than 100 000 pathogenic bacteria/ml of urine.
The presence of infection was defined as a fever index score of> 8°h (calculated as the area beneath the temperature observation line above 37"C), a maximum body temperature of > 38°C, leucocytosis (> 10 000 cells/ ~l), an erythrocyte sedimentation rate (ESR) exceeding 50 mm/h, and the presence of 3 positive (+++) C-reactive proteins (Sakai et al. 1985) . Each of these criteria was allotted 1 point in the overall assessment.
Statistical Analysis
Mean ± standard deviation (SD) values were calculated for all data. The x 2 test was used to assess homogeneity of variance using Yates' correction. Student's t-test and the Wilcoxon rank sum test were used to compare differences between median fever index values. Statistical significance was established with a probability value (p) of < 0.05.
Results
Clinical and follow-up data were available for all patients and are presented in table I. Gender, age, primary disease, category of surgery, operation time and volume of blood loss did not differ significantly between the 2 treatment groups. The average duration of drug administration was 5.7 days for the cefazolin group and 5.8 days for the ceftizoxime group. The average total dose ingested was 22.5g for cefazolin and 11.8g for ceftizoxime.
Postoperative Complications
A total of 7 (11.5%) cefazolin-treated patients and 5 (8.9%) ceftizoxime-treated patients experienced postoperative complications related to infection (table II) . There was no significant difference in the incidence of this parameter or the incidence of noninfection-related complications between the 2 treatment groups. Furthermore, although intra-abdominal infections occurred more
